News

A study revealed that particpants who received Arimidex and Herceptin in combination demonstrated an extended median progression-free survival of 4.8 months, representing an extension of 2.4 months over

The preliminary injunction was requested by Novo Nordisk as part of a patent infringement case that will be heard by the same court. Novo Nordisk had sued Pfizer

Following the redundancies, Adolor’s headcount will stand at 128, down from 180. The company expects to take a one time charge of approximately $2-3 million in the fourth

As a result of the acquisition, Forest will obtain development and marketing rights worldwide excluding Japan for two antibiotics, Ceftaroline and ME1036. Ceftaroline will enter phase III trials

Under the terms of the deal, Sinclair will supply Aloclair Spray to Omni Preventive Care, which will be responsible for the marketing and distribution of the product in

The computer model of human physiology structures data in a way that enables identification of the key factors associated with the development of skin sensitization. Entelos claims the

The analysis was conducted by an independent data safety monitoring board (DSMB). In addition to its recommendation that the trial continue, the DSMB supported the use of endoscopic

The license agreement will specifically be aimed at the development and commercialization of OSI’s dipeptidyl peptidase IV (DPIV) inhibitors for the treatment of type 2 diabetes. OSI will

Two phase III clinical trials were conducted to evaluate the safety and efficacy of Aloxi compared to placebo for the prevention of post-operative nausea and vomiting following elective